Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 49Lymphoma 39Lymphoma, Non-Hodgkin 31Hodgkin Disease 22Lymphoma, Follicular 18Burkitt Lymphoma 17Lymphoma, Mantle-Cell 15Leukemia, Lymphocytic, Chronic, B-Cell 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large-Cell, Immunoblastic 14Lymphoma, Large-Cell, Anaplastic 14Lymphoma, B-Cell, Marginal Zone 14Lymphoma, B-Cell 11Leukemia, Myeloid, Acute 10Immunoblastic Lymphadenopathy 9Waldenstrom Macroglobulinemia 8Leukemia, Myelomonocytic, Chronic 8Blast Crisis 8Recurrence 7Leukemia, Myeloid, Accelerated Phase 7Leukemia 7Dendritic Cell Sarcoma, Interdigitating 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Chronic-Phase 6Neuroblastoma 5Mycosis Fungoides 5Multiple Myeloma 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 5

Interventions

Cyclophosphamide 8Rituximab 7fludarabine 6dacetuzumab 6fludarabine phosphate 5blinatumomab 4Bortezomib 4ibrutinib 3Melphalan 3Lenalidomide 3Ifosfamide 3Etoposide 3Dexamethasone 3Bendamustine Hydrochloride 3AP 1903 reagent 3ponatinib 2cobomarsen 2Whole-Body Irradiation 2Vorinostat 2Vincristine 2Tacrolimus 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Doxorubicin 2Carboplatin 2Busulfan 2Brentuximab Vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Immunoproliferative Disorders × Carboplatin × Lymphoid × Clear all
NCT02592876 2019-05-17

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Seagen Inc.

Phase 2 Terminated
81 enrolled 15 charts
Lymphoid

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00529503 2015-02-25

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Seagen Inc.

Phase 2 Terminated
151 enrolled
Lymphoid

Hematologic Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡